X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13397) 13397
Book Chapter (144) 144
Magazine Article (21) 21
Conference Proceeding (7) 7
Web Resource (3) 3
Newspaper Article (2) 2
Streaming Video (2) 2
Book / eBook (1) 1
Book Review (1) 1
Publication (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11921) 11921
rituximab (11771) 11771
science & technology (10220) 10220
life sciences & biomedicine (10050) 10050
female (6111) 6111
male (5986) 5986
middle aged (5006) 5006
antibodies, monoclonal, murine-derived (4306) 4306
adult (4199) 4199
antibodies, monoclonal - therapeutic use (3898) 3898
aged (3838) 3838
treatment outcome (3818) 3818
hematology (3106) 3106
antineoplastic combined chemotherapy protocols - therapeutic use (2943) 2943
oncology (2839) 2839
antibodies, monoclonal, murine-derived - therapeutic use (2834) 2834
antineoplastic agents - therapeutic use (2159) 2159
rituximab - therapeutic use (2078) 2078
immunologic factors - therapeutic use (2041) 2041
lymphomas (1631) 1631
aged, 80 and over (1495) 1495
immunosuppressive agents - therapeutic use (1487) 1487
care and treatment (1394) 1394
retrospective studies (1387) 1387
rheumatology (1385) 1385
prognosis (1262) 1262
cyclophosphamide - administration & dosage (1244) 1244
antibodies, monoclonal, murine-derived - administration & dosage (1227) 1227
chemotherapy (1197) 1197
antibodies, monoclonal - administration & dosage (1178) 1178
young adult (1169) 1169
adolescent (1145) 1145
lymphoma, large b-cell, diffuse - drug therapy (1137) 1137
abridged index medicus (1132) 1132
medicine & public health (1111) 1111
immunology (1109) 1109
cancer (1089) 1089
remission induction (1081) 1081
cyclophosphamide - therapeutic use (1054) 1054
patients (1039) 1039
transplantation (992) 992
recurrence (981) 981
vincristine - administration & dosage (955) 955
antirheumatic agents - therapeutic use (946) 946
lymphoma (897) 897
doxorubicin - administration & dosage (894) 894
immunotherapy (891) 891
drug therapy (884) 884
follow-up studies (880) 880
antineoplastic combined chemotherapy protocols - administration & dosage (879) 879
disease-free survival (847) 847
hemic and lymphatic diseases (823) 823
prednisone - administration & dosage (818) 818
general & internal medicine (796) 796
animals (795) 795
rituximab - administration & dosage (783) 783
monoclonal antibodies (765) 765
combined modality therapy (761) 761
medicine, general & internal (760) 760
rheumatoid arthritis (759) 759
antibodies, monoclonal - adverse effects (757) 757
drug therapy, combination (752) 752
b-lymphocytes - immunology (748) 748
cyclophosphamide (746) 746
risk factors (745) 745
lymphoma, b-cell - drug therapy (743) 743
antigens, cd20 - immunology (732) 732
antineoplastic agents (730) 730
child (719) 719
analysis (714) 714
prednisone - therapeutic use (710) 710
health aspects (697) 697
antibodies, monoclonal, murine-derived - adverse effects (690) 690
arthritis, rheumatoid - drug therapy (689) 689
antineoplastic combined chemotherapy protocols - adverse effects (685) 685
antimitotic agents (679) 679
lymphoma, non-hodgkin - drug therapy (674) 674
research (674) 674
leukemia, lymphocytic, chronic, b-cell - drug therapy (633) 633
time factors (631) 631
pharmacology & pharmacy (624) 624
vincristine - therapeutic use (605) 605
lymphocytes b (593) 593
immune system diseases (585) 585
lymphoma, follicular - drug therapy (579) 579
doxorubicin - therapeutic use (571) 571
clinical trials (545) 545
immunoglobulins (543) 543
lymphoma, large b-cell, diffuse - pathology (533) 533
b-lymphocytes - drug effects (527) 527
drug administration schedule (520) 520
biopsy (510) 510
clinical trials as topic (510) 510
survival analysis (498) 498
pediatrics (485) 485
internal medicine (481) 481
neurosciences & neurology (481) 481
antibodies (480) 480
surgery (476) 476
corticosteroids (463) 463
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12773) 12773
Japanese (279) 279
French (213) 213
Spanish (162) 162
German (157) 157
Chinese (127) 127
Italian (45) 45
Russian (40) 40
Portuguese (32) 32
Hungarian (26) 26
Czech (24) 24
Polish (24) 24
Danish (16) 16
Croatian (11) 11
Hebrew (9) 9
Dutch (8) 8
Norwegian (8) 8
Korean (7) 7
Finnish (6) 6
Serbian (2) 2
Swedish (2) 2
Bosnian (1) 1
Estonian (1) 1
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Medical clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 621 - 634
Type 1 diabetes is an autoimmune disease that gradually destructs insulin-producing beta cells. Over the years, clinicians' knowledge regarding the... 
Immunosuppressants | Transplantation | Diabetes mellitus type 1 | Immunomodulators | Immunotherapies | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Azathioprine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Insulin - immunology | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Fatty Acids, Unsaturated - therapeutic use | Pyrazines - therapeutic use | Secondary Prevention | Diabetes Mellitus, Type 1 - therapy | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Glutamate Decarboxylase - therapeutic use | Antilymphocyte Serum - therapeutic use | Immunoconjugates - therapeutic use | Islets of Langerhans Transplantation | Diabetes Mellitus, Type 1 - immunology | Sitagliptin Phosphate | Tertiary Prevention | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Primary Prevention | Antibodies, Monoclonal, Humanized - therapeutic use | Interferon-alpha - therapeutic use | Immunoglobulin G - therapeutic use | Niacinamide - therapeutic use | Rituximab | Vitamins - therapeutic use | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Diet | Venoms - therapeutic use | Peptide Fragments - therapeutic use | Vitamin D - therapeutic use | Chaperonin 60 - therapeutic use | Insulin - therapeutic use | Peptides - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Hypoglycemic Agents - immunology
Journal Article
The Medical clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Journal Article
Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
Journal Article
BMJ Open, ISSN 2044-6055, 01/2017, Volume 7, Issue 1, pp. e014032 - e014032
... and severe HZ. The use of long-term medical records: a 14-year follow-up period (2001–2014) enhanced the statistical power and accuracy of this study. The present study... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hydroxychloroquine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Herpes Zoster Ophthalmicus - epidemiology | Leflunomide | Methotrexate - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Case-Control Studies | Young Adult | Rituximab - therapeutic use | Time Factors | Arthritis, Rheumatoid - drug therapy | Adult | Female | Herpes Zoster - epidemiology | Odds Ratio | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Severity of Illness Index | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Factors | Adalimumab - therapeutic use | Abatacept - therapeutic use | Taiwan - epidemiology | Aged | Isoxazoles - therapeutic use | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Etanercept - therapeutic use | Drugs | Codes | Biological products | Bacterial infections | Comorbidity | Rheumatology | Medical records | Infections | Epidemiology | Patients | Studies | Databases | Rheumatoid arthritis | Older people | Human immunodeficiency virus--HIV | Population | TNF inhibitors | Tumor necrosis factor-TNF | Health risk assessment | Viral infections | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2016, Volume 2016, Issue 6, pp. CD008334 - CD008334
Journal Article